Todas as matérias desta categoria, das mais recentes às mais antigas.
Sagimet Biosciences (NASDAQ:SGMT) announced 52-week results from license partner Ascletis’ Phase 3 open-label extension trial of denifanstat in moderate to severe acne, with treatment success reaching 56.7% among 240 patients.
Solidion Technology (NASDAQ:STI) announced its intent to pursue an all-cash acquisition of Flux Power Holdings (NASDAQ:FLUX) through a non-binding proposal, with no definitive agreement currently executed.
Cal-Maine Foods (NASDAQ:CALM) reported a first-quarter fiscal 2027 net loss attributable to the company of $58.615 million, reversing a year-earlier profit as net sales declined 41.5% to $539.607 million.
Concentrix Corporation (NASDAQ:CNXC) shares declined 11.5% premarket to $22.02 after the technology and services company reported a third-quarter 2026 loss following a $1.05 billion non-cash goodwill impairment charge.
AbbVie (NYSE:ABBV) announced Phase 1 results for investigational ABBV-295, reporting adjusted mean weight reductions of up to 9.8% after 12 weeks of weekly dosing in a study involving 60 participants.
Yiren Digital (NASDAQ:YRD) reported a second-quarter 2026 net loss of RMB449.6 million, compared with net income of RMB357.5 million a year earlier, as revenue declined 46% year over year to RMB890 million.
Banca Monte dei Paschi di Siena Chief Executive Officer Luigi Lovaglio tells Bloomberg Television he is confident shareholders will recognize the value of his twin takeover offers for Banco BPM and Banca Generali. "We are building an Italian champion," Lovaglio says. The CEO needs support from at least two thirds of the votes cast at a shareholder meeting on Oct. 29 to proceed with his plan. Lovaglio speaks to Bloomberg's Francine Lacqua.
Oil prices were largely steady on Wednesday after a sharp decline in the previous session, as recovering Middle East exports reduced some supply concerns linked to disruptions through the Strait of Hormuz.
Peter Oppenheimer, chief global equity strategist at Goldman Sachs, says European stocks have remained resilient and have "done rather well" in the face of inflationary pressures and rising bond yields. He also comments on French bond yields. Speaking on Bloomberg Television, Oppenheimer says the profit story "is still solid," but should markets experience a further sharp bond selloff, equities could "become vulnerable."
Apollo (NYSE:APO) announced that its managed funds completed the acquisition of Nippon Sheet Glass, a company operating in architectural, automotive and solar glass markets, and launched a new management structure.
Takeda (NYSE:TAK) announced Phase 3 LATITUDE study results for investigational drug zasocitinib (TAK-279), reporting statistically significant improvements compared with deucravacitinib in adults with moderate-to-severe plaque psoriasis.
AbbVie (NYSE:ABBV) announced that it will present 60 dermatology research abstracts, including three late-breaking presentations, at the 2026 European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria, covering multiple immune-mediated skin diseases.
